pharma · Obesity, Overweight · Type 2 Diabetes
Eli Lilly and
Eli Lilly Co.
Eli Lilly and clinical programs — 21 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Lilly Corporate Center, Indianapolis, Indiana 46285, US
- Founded
- 1876
- Employees
- 55,860
- Programs
- 107
- Drugs
- 99
- Patents
- 0
Eli Lilly and projects
21 ClinicalTrials.gov programs sponsored by Eli Lilly and.
Eli Lilly and has 21 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
0.9% sodium chloride, GADOTERIC ACID
Eli Lilly Co.
Relapsing Multiple Sclerosis
1 trial -
Eltrekibart, 0.9% sodium chloride
Eli Lilly Co.
Moderate to Severe Hidradenitis Suppurativa
1 trial -
Flortaucipir, Placebo to match LY3372689
Eli Lilly Co.
Alzheimer Disease
1 trial -
I3Y-MC-JPCS
Eli Lilly Co.
Relapsed/Refractory Solid Tumors
1 trial -
I3Y-MC-JPEH
Eli Lilly Co.
Glioma
1 trial -
I5T-MC-AACI
Eli Lilly Co.
Alzheimer Disease
1 trial -
I7P-MC-DSAG
Eli Lilly Co.
Ulcerative Colitis
1 trial -
I8F-MC-GPIG
Eli Lilly Co.
Chronic Kidney Disease, CKD, Obesity, Overweight, T2D, Type 2 Diabetes
1 trial -
J1I-MC-GZBU
Eli Lilly Co.
Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
1 trial -
J1R-MC-GZFD
Eli Lilly Co.
Type 2 Diabetes
1 trial -
J1S-MC-JP04
Eli Lilly Co.
Ewings Sarcoma
1 trial -
J2R-MC-YAAD
Eli Lilly Co.
Nausea, Drug-Related Side Effects and Adverse Reactions, Vomiting, Neoplasms
1 trial -
J2S-MC-GZMR
Eli Lilly Co.
Asthma
1 trial -
J6E-MC-KWAN
Eli Lilly Co.
Ulcerative Colitis
1 trial -
LOXO-RAS-20001
Eli Lilly Co.
KRAS G12C-Mutant Advanced Solid Tumors
1 trial -
LY2875358, ERLOTINIB
Eli Lilly Co.
Non-Small Cell Lung Cancer
1 trial -
Pirtobrutinib, Placebo tablets
Eli Lilly Co.
Immune Thrombocytopenia
1 trial -
Placebo to match LY3540378
Eli Lilly Co.
Heart Failure with Preserved Ejection Fraction, Heart Failure
1 trial -
Placebo to match LY3556050
Eli Lilly Co.
Diabetic Peripheral Neuropathy
1 trial -
Placebo to match LY3848575
Eli Lilly Co.
Neuropathic Pain; Distal Sensory Polyneuropathy
1 trial -
Verzenios 50 mg film-coated tablets, TAMOXIFEN
Eli Lilly Co.
Metastatic Breast Cancer
1 trial
Frequently asked questions
How many clinical projects does Eli Lilly and have?
21 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.